Latest / CLEs You Actually Want to Hear / Patent Litigation Strategy in an Era of Shifting USPTO Proceedings
Transcript
- 0:03Good afternoon, everyone, and welcome to Patent
- 0:06Litigation Strategy in an Era of Shifting USPTO
- 0:10Proceedings. I'm Adrian Syhan, Intellectual Property
- 0:14and Technology Transactions Partner at Stubbs
- 0:17Alderton and Chair of the Beverly Hills Bar Association's
- 0:21IP Law Section. And I'm delighted today to introduce
- 0:24our speaker, Christopher Kao. Christopher is
- 0:27a partner at Pillsbury Winthrop Shaw -Pittman
- 0:29LLP, where he leads the firm's intellectual property
- 0:33litigation practice group and co -leads its Taiwan
- 0:36practice. A seasoned first chair trial lawyer,
- 0:39he represents technology, semiconductor, telecommunications,
- 0:43and biotechnology companies in high stakes patents,
- 0:47copyright, trademark, and trade secret disputes
- 0:50before federal and state courts, the US International
- 0:53Trade Commission, and the Federal Circuit. and
- 0:56has secured favorable rulings, including federal
- 0:58circuit -affirmed judgments and validating asserted
- 1:01patents. He has been recognized by IAM Patent
- 1:051000, and the Daily Journal is one of California's
- 1:09top IP lawyers, as well as best IP lawyers for
- 1:12his work in IP and patent litigation. We're very
- 1:15happy to have you, Chris, and now let's get started.
- 1:19Great. Well, thank you, Adrian. And thanks to
- 1:22the Beverly Hills Bar Association for inviting
- 1:24me to talk today. I'm going to now share my screen
- 1:29so everyone can see the slides. I'll try to leave
- 1:33a little bit of time to answer questions at the
- 1:37end of the presentation. So feel free to submit
- 1:40your questions in the Q &A box, I believe is
- 1:45where the questions will. is the best place to
- 1:48submit the questions. So why don't we move to
- 1:52the next slide? So the topic for today is patent
- 2:02litigation in the context of the changing rules
- 2:06and procedures at the U .S. Patent Office with
- 2:10respect to post -grant challenges. And so what
- 2:16I thought I would do is just walk through the
- 2:21system that was originally created that allowed
- 2:24these types of post -grad proceedings back in
- 2:272012, and then talk about the different shifts
- 2:31over time at the USPTO that were largely driven
- 2:36by each new administration and each new director
- 2:41of the US Patent Office. which has sort of ping
- 2:46-ponged back and forth over time in terms of
- 2:49how these proceedings are treated and the criteria
- 2:55for accepting these challenges. And then as we
- 2:59go through this, I'll discuss the impact that
- 3:02that has had on patent litigation proceedings
- 3:05in district courts. So next slide. So first,
- 3:14what are these post -grad proceedings? As those
- 3:18of you who practice IP primarily, you're well
- 3:22aware of these things, but for those who don't
- 3:25know, the America Events Act, the AIA, created
- 3:31what is called the Patent Trial and Appeal Board,
- 3:35the PTAB, at the US Patent Office. And this was
- 3:39modeled after the Trademark Trial and Appeal
- 3:41Board, which had existed for years. And the PTAB
- 3:47is essentially an administrative law body composed
- 3:51of, today, hundreds of administrative law judges.
- 3:57who were hired to address these new post -crant
- 4:03proceedings. And at the time when this went into
- 4:08place in 2012, petitioners could file challenges
- 4:13to issued US patents. And there were essentially
- 4:17three different forms of new proceedings that
- 4:20were created. One was the covered business method
- 4:25review. And that was intended to allow petitioners
- 4:31to challenge business method patents, which had
- 4:35come under a lot of scrutiny in the 2000s. And
- 4:40that program only existed for a limited period
- 4:43of time. There was a limited window in which
- 4:46the patent office was gonna consider these CBMs.
- 4:50So that's now ended. So there no longer is a
- 4:54CBM program at the patent office. But the two
- 4:58other, types of post -grant proceedings still
- 5:02exist today. One is the inter -parties review,
- 5:08or what we call IPRs, and then post -grant reviews,
- 5:12PGRs. The primary difference between the two
- 5:16is that inter -parties reviews are limited in
- 5:21the types of challenges that you can bring to
- 5:23patents. So in particular, for IPRs, when you
- 5:30challenge a patent that has been issued, you
- 5:32are only able to rely on prior, you know, patents,
- 5:39prior art patents or other printed publications.
- 5:43So, you know, journal articles, other types of
- 5:45publications. that will show that the patent
- 5:49that you're challenging was either anticipated
- 5:53by this prior art or made obvious by the prior
- 5:57art. And so IPRs allow you only to challenge
- 6:02under those limited conditions. PGRs, by contrast,
- 6:08allow petitioners to challenge issued U .S. patents
- 6:13on basically all of the different types of grounds
- 6:17for invalidity that you can make. So that includes
- 6:22anticipation and obviousness that are covered
- 6:26by IPRs. But it also extends to other types of
- 6:30invalidity, such as under section 101, which
- 6:35relates to whether the subject matter of the
- 6:37patent is patentable in the first place. So that's
- 6:41something you can't challenge in an IPR, but
- 6:43is available in a PGR. You can also challenge
- 6:48patents in a PGR. based on other criteria for
- 6:55patentability, including the written description
- 6:58requirement, whether the patent adequately describes
- 7:01the invention and all of the ways that the US
- 7:05Patent Office considers. The difference is for
- 7:10post -grant reviews, you only have a very limited
- 7:13window to challenge patents. You have to file
- 7:18your petition within the first nine months after
- 7:23the patent issues. So after the US Patent Office
- 7:26grants the patent, you have nine months to make
- 7:30that challenge. And after that, your only option
- 7:33is an IPR. For that reason, there has never actually
- 7:41been a whole lot of PGRs filed. And that has
- 7:47continued today, although there is an increase
- 7:50today for the reasons that we're going to talk
- 7:52about in this presentation, still the number
- 7:55of PGRs that are filed at the USPTO is pretty
- 7:58low. And that is because, you know, within the
- 8:02first, you have to really be closely tracking
- 8:05new issued patents in order to be able to file
- 8:09your petition within that window. And oftentimes
- 8:13in terms from the litigation perspective, most
- 8:18litigation matters, most patent infringement
- 8:20cases that are filed typically assert patents
- 8:24that have been around for a longer period of
- 8:28time. So, and there's a variety of reasons for
- 8:32that, including. you know, in terms of damages,
- 8:36to seek damages for a greater period, you typically
- 8:41want to assert patents if you're the patent owner
- 8:45that have issued for a longer period of time.
- 8:48So there's a longer scope for your damages period.
- 8:52Whereas if on a newly issued patent that just
- 8:55came out, you would only have a few months of
- 8:58damages. So that is not as attractive for patent
- 9:02owners to assert those types of patents. So the
- 9:08bulk of the post -grant proceedings filed beginning
- 9:14at 2012 through today are IPRs. And we'll talk
- 9:20about how many of these get filed at the USPTO.
- 9:24But that makes up the vast majority of post -grant
- 9:27proceedings. So for IPRs, the standard that's
- 9:32set forth in the statutes in the AIA in 2012
- 9:36was pretty simple. The petition that you file
- 9:40with the PTO has to show that there is a reasonable
- 9:45likelihood that the petitioner would prevail
- 9:49with respect to at least one of the claims, one
- 9:53of the patent claims challenged in the petition.
- 9:56And that is the standard for institution set
- 10:00forth in the AIA. So next slide, please. So after
- 10:08the creation of this program in 2012, in the
- 10:11first few years of the PTAB, the institution
- 10:15rate for IPRs was in the 65 to 70 % range. So
- 10:20that means that, you know, roughly two thirds
- 10:23of the time that somebody sought to challenge
- 10:27and issued U .S. patents, the PTO would institute
- 10:32a review, would commence a review. That doesn't
- 10:36mean that in all of those cases, the patents
- 10:39ended up being invalidated, but that's the the
- 10:44rate at which the USPTO would at least consider
- 10:48the challenge. And the statistics for the final
- 10:54invalidity of patents was also roughly in that
- 10:57same 60 % range. So after institution, roughly
- 11:0560 % of the time, at least one claim, if not
- 11:08all of the claims of the patent, would be invalidated
- 11:12by the PTAP. And that was generally the state
- 11:17of play in the first four years or so of the
- 11:20program. So because of the pretty high institution
- 11:26rate and high invalidity rate, IPRs became a
- 11:31very, very popular tool, particularly for defendants
- 11:35in patent litigation in district courts. And
- 11:39the number of IPR petitions grew from around
- 11:44200 in the very first year of the program to
- 11:48around 1 ,500 petitions that were filed in 2016.
- 11:53So a pretty large increase. And from a patent
- 11:56defendant's perspective, IPRs were considered
- 12:01in almost every case. So basically in every case,
- 12:04And I should say that my work is mostly on the
- 12:09defense side. So I primarily represent defendants
- 12:13in patent litigation. We consider IPRs as a potential
- 12:21strategy in basically every case that was filed
- 12:25after 2012. And there's a number of reasons for
- 12:30that, which I've listed here. So one, IPRs are
- 12:34less expensive than district court litigation.
- 12:38They're generally faster than district court
- 12:40litigation. Under the statute, under the AIA,
- 12:45the PTAB has to make after the institution decision.
- 12:49And that typically occurs within, based again
- 12:53on the statute, within the first six months after
- 12:56you file the petition, there's an institution
- 12:58decision within six months. And then after that,
- 13:02as a general matter, the PTAB has to issue its
- 13:05final decision on the IPR within one year of
- 13:10institution. So all told, you're looking at roughly
- 13:1318 months, which is generally faster than most
- 13:18courts in this country address patent litigation.
- 13:22In addition, the other benefit of IPRs as opposed
- 13:26to litigating the validity of a U .S. patent
- 13:29in district court is the PTAB, as I mentioned,
- 13:33is composed of administrative law judges who
- 13:37are all experienced patent practitioners, right?
- 13:41So the ALJs were comprised of examiners, former
- 13:49examiners. of former patent litigators like myself,
- 13:54and they were the ones who were hired to be the
- 13:57PTAB judges to decide these. And so they're generally
- 14:01knowledgeable about patent law, about technology,
- 14:04and much more suited to deciding the invalidity
- 14:09of patents versus a lay jury, many of whom know
- 14:14nothing about patents or the patent system or
- 14:17technology. And so that's why IPRs became very
- 14:21popular and became a very important tool for
- 14:25defendants in patent litigation as a way to invalidate
- 14:28the patents outside of the district court system.
- 14:33Next slide, please. So what has been happening
- 14:40since then? In 2018, Under a new administration
- 14:47and a new patent office director who came in,
- 14:50who was appointed in the first Trump administration,
- 14:57Director Andre Iancu was the patent office director
- 15:03during this time. During his tenure at the patent
- 15:06office, the PTAB first introduced the concept
- 15:09of what are called discretionary denials. And
- 15:15at first, this started with an evaluation of
- 15:22the stage of the proceedings, the district court
- 15:27litigation. And the notion was that if it appeared
- 15:33that the district court case was going to...
- 15:36go to trial and have a decision before the patent
- 15:41office, the PTAB, could issue its decision. In
- 15:462018, the PTAB first began thinking and denying
- 15:52institution on that grounds that, well, if the
- 15:56district court case is going to go to trial first,
- 15:59then we should just let that process play out.
- 16:02And there's no need for the patent office to
- 16:04conduct a review of the same patent. And subsequently,
- 16:10the PTAB established what are known in the industry
- 16:14as the fintive factors. based on a definitive
- 16:17decision. And I've listed the factors here, but
- 16:22they basically are similar to what was first
- 16:24described in the NHK decision, which is. The
- 16:28PTAB said that it would look at whether the district
- 16:32court was stayed, the district court case was
- 16:36stayed, or whether the court would be likely
- 16:39to stay the case pending the IPR proceedings
- 16:45at the PTAB. And obviously, if the case was gonna
- 16:47be stayed, I mean, that way is in favor of proceeding
- 16:51at the PTAB. The PTAB would also look at, you
- 16:55know, again, how close the trial date was versus
- 16:58the PTAB's final written decision deadline and
- 17:02other factors that basically relate to whether
- 17:06it, you know, how many of these issues were going
- 17:10to be litigated in the district court, whether
- 17:14there were other district courts or IPR proceedings
- 17:19involving the same patent already, and all of
- 17:25those different factors. And so as a result of
- 17:29all of these factors and the application of these
- 17:33factors, we saw a decline in the number of IPRs
- 17:38that were instituted during this time from 2018
- 17:43to 2021. Next slide, please. that went to the
- 17:54very end. If we can go back up to slide, there
- 17:59is probably like four, nope, sorry, six. Okay,
- 18:12so as a result of these sort of discretionary
- 18:16denials, the institution rate for IPRs gradually
- 18:22fell from about 63 % in 2016 to a new low of
- 18:2856 % in 2020. So whereas previously in the first
- 18:32few years of the program, you had a 65 to 70
- 18:36% chance of getting an IPR instituted, that went
- 18:40down to about 50%. And as a result, the number
- 18:44of IPR petitions filed also fell from the high
- 18:49of about 1500 to around 1100. So a pretty sizable
- 18:55decrease. Nevertheless, defendants in patent
- 19:01cases continued to look at IPR as a strategy
- 19:04in every case. It just meant that you had to
- 19:09make more. considered decisions about whether
- 19:13it made sense to invest the time and the money
- 19:16in filing IPRs if the institution rate was only
- 19:20going to be about 50 % versus 65 to 70%. So that's
- 19:27the first shift away from the high institution
- 19:33rates for IPRs. Next slide, please. In 2021,
- 19:42there was a new administration and a new Patent
- 19:46Office Director was appointed, Kathy Vidal. And
- 19:50under her tenure at the U .S. Patent Office,
- 19:55things sort of returned back to where they were
- 19:57in the early years of the post -grant challenge
- 20:03system. So during the years that Director Vidal
- 20:08was in charge of the PTO, institution rates went
- 20:12back up to the pre -2018 institution rates. So
- 20:16in 2024, for example, the institution rate was
- 20:19at 68%, which is consistent with sort of the
- 20:2365 to 70 % range in the early years of the program.
- 20:28And the PTAB sharply reduced the number of discretionary
- 20:33denials that were created in 2018. And so the
- 20:37focus really was on, you know, the standard that
- 20:43had been established, set forth in the statute.
- 20:46So the PTAB was really looking to see whether
- 20:48there was a reasonable likelihood of success
- 20:51in invalidating the patent in making the institution
- 20:54decision. versus the hyper focus on whether the
- 21:02trial court was going to reach trial faster than
- 21:06the PTAB. It was more of a look at the sort of
- 21:10the substance of the petition versus timing issues
- 21:13and other ancillary discretionary denial factors.
- 21:18Next slide. So in particular, Director Vidal
- 21:26issued a memorandum, a formal memorandum in 2022,
- 21:31setting forth the PTO's policy at the time. And
- 21:36in effect, that memo instructed the PTAB judges
- 21:43that they should not, in considering whether,
- 21:48to make a discretionary denial of an IPR petition,
- 21:54that they should not, you know, issue a discretionary
- 21:59denial if the petitioner made what is called
- 22:04a Sotera stipulation. And all that really means
- 22:07is Sotera is the PTAP decision that talks about
- 22:11this. But essentially it means that the petitioner
- 22:16has to agree that based on what the IPR and the
- 22:22PTAB decides, the petitioner would agree not
- 22:25to re -raise those same issues at the district
- 22:28court. So not to waste the court's time or the
- 22:31jury's time with issues that were raised in the
- 22:35IPR or could have been raised in the IPR. So
- 22:38as long as the petitioner was willing to agree
- 22:40to that, And the petition made a compelling showing
- 22:46on the merits. The PTAB's instruction was to
- 22:50not deny institution of IPRs. And as we can see
- 22:55from the statistics, they implemented that policy
- 23:02during the years that Director Vidal was at the
- 23:05PTO. Next slide, please. Okay. So what's going
- 23:12on today? There has been major changes in the
- 23:18last year and a half, which are important to
- 23:22discuss. And this sort of second shift with respect
- 23:29to post -grant challenges and IPRs began after
- 23:34Director Vidal stepped down as the PTO director.
- 23:39and initially acting director Coke Morgan Stewart
- 23:45took over and eventually director John Squires
- 23:49after he was appointed and confirmed to replace
- 23:52director Fadal. So what has been happening? Next
- 23:56slide. So beginning in February, 2025, when acting
- 24:09director Stewart took over, she issued a memo
- 24:13rescinding director Vidal's 2022 memo and essentially
- 24:21say that the PTAB should apply the fintive factors
- 24:27again and should look to, you know, deny IPR
- 24:37petitions on a discretionary basis wherever it
- 24:42was appropriate and consistent with the fintive
- 24:44factors. And in particular, the director noted
- 24:53that essentially expanded the latitude and instructed
- 25:00that the the PTAB had wide discretion to deny
- 25:07on a discretionary basis IPRs on almost any basis
- 25:11that they thought was appropriate. This was followed
- 25:15by the chief judge of the PTAB at the time, Bullock's
- 25:20memo, where he set forth, again, this was an
- 25:24instruction to the PTAB judges, that Sotera stipulations
- 25:29are highly relevant but no longer dispositive.
- 25:33So the mere fact that a petitioner filed a Sotera
- 25:36stipulation, which under Director Vidal's regime,
- 25:40essentially meant that there shouldn't be a discretionary
- 25:43denial, would no longer be dispositive. compelling
- 25:48merits. So even if you had a very strong case
- 25:51on the merits, that would also not be dispositive.
- 25:55That no matter how strong the petition was substantively,
- 26:00if these other discretionary denial factors could
- 26:07take could take precedent and could compel discretionary
- 26:11denial. In other words, the timing issue may
- 26:15be dispositive no matter how strong the petition
- 26:18was. And importantly, the chief judge's memo
- 26:23also said that the PTAB could defer to district
- 26:27court schedules and assume that the trial would
- 26:33happen as scheduled. sort of important because,
- 26:39as you know, the litigators who are attending
- 26:43today will know that it's the case that the initial
- 26:48trial date set by district court, in any case,
- 26:52most often is never, you know, correct, right?
- 26:55It never actually happens on the schedule that
- 26:58is set. the first day where the judge issues
- 27:02the scheduling order for the case. Schedules
- 27:04of litigation are often extended because of discovery
- 27:09reasons, because of expert discovery. And so
- 27:12the trial date is never typically the first date
- 27:16that is set. Trial may happen a year after that
- 27:20initial trial date. the chief judge instructed
- 27:25the PTAB that, well, let's just assume that that
- 27:28first date will stick. Because what PTAB judges
- 27:31had been deciding during the prior four years
- 27:36was that those dates are really not that reliable,
- 27:39and that that really should not be a reason to
- 27:42discretionarily deny an IPR just based on the
- 27:45initial trial date set. Because if you look more
- 27:49holistically at a trial's trial court statistics,
- 27:53you would see that that's probably a better indicator
- 27:56of when a trial would happen, not looking specifically
- 28:00at the trial date set in a case. But he instructed
- 28:05that you could just defer to the initial schedule.
- 28:13Acting Director Stewart followed her initial
- 28:15memo with a subsequent memo in March 2025. Again,
- 28:20sort of highlighting the number of IPRs that
- 28:24were in process at the PTAB and raising concerns
- 28:29about that caseload. Again, essentially suggesting
- 28:34to the PTAB judges that they should be inclined
- 28:38to, you know. deny IPR petitions on a discretionary
- 28:46basis more often to reduce the caseload at the
- 28:51PTO. So with that backdrop, Director Squires
- 28:58then came into the PTO and basically around the
- 29:05beginning of this year, and he changed the procedures
- 29:09even further. So during acting director Stewart's
- 29:15time, although they were not lengthy institution
- 29:21decisions, the PTAB was at least issuing sort
- 29:27of short discretionary denial decisions explaining
- 29:31some of the reasons why the IPR was denied on
- 29:36a discretionary basis. Since Director Squires
- 29:40has taken over, there's really no written analysis
- 29:45at all. The director is basically issuing on
- 29:48a regular basis a list by number that says, okay,
- 29:54IPR petitions one, two, three, four, and five
- 29:57are denied on a discretionary basis. You know,
- 30:02numbers six, seven, eight, nine are, you know,
- 30:07are going to proceed to a merits consideration.
- 30:13And then if he would later that issue another
- 30:16memo that would say, okay, I've now looked at
- 30:19the merits of six, seven, eight, nine, and I'm
- 30:23either going to institute or not institute. So
- 30:26there's, we've gone from a system where they
- 30:29were really, you know, fairly lengthy institution
- 30:34decisions. prior to 2025 to very short discretionary
- 30:43denial decisions to no decisions at all. It's
- 30:47just pure yes or no, institute or not institute.
- 30:52The other change is that Director Squires is
- 30:54making all of these decisions on his own. So
- 30:59previously, when an IPR petition was filed, the
- 31:04petition would be assigned to a panel of ALJs.
- 31:09So each IPR was assigned to a panel of three
- 31:14ALJs who would decide whether to institute or
- 31:18not and then decide the final, you know, substantive
- 31:21decision on whether the petitioner had proved
- 31:25that the patent was invalid or not. And that
- 31:31was the process through 2025. Currently at the
- 31:36PTO, Director Squires is making all of those
- 31:39decisions on his own without having the ALJs,
- 31:47without their being involved. And essentially
- 31:49once he institutes an IPR, then and only then
- 31:54is the as the IPR assigned to the panel of ALJs
- 31:59to handle the proceedings from there on forward.
- 32:03Next slide. So what is happening as a result
- 32:11of all of these sort of rule changes and procedural
- 32:13changes at the PTO? The upshot is that basically
- 32:19now, the PTO and the PTO director Squires is
- 32:25basically looking for any, in my opinion, any
- 32:30excuse to deny IPR petitions to whittle down
- 32:33the IPR docket. So we're seeing massive, massive
- 32:38increases in discretionary denials of IPR that
- 32:41were previously unheard of. And as I mentioned,
- 32:46there's sort of limited or superficial analysis
- 32:48in those orders. And what that has led to is,
- 32:55oh, and I guess I should mention at least during
- 32:57the time period where under acting director Stewart,
- 33:02there were at least short decisions. The key
- 33:05factors that at least she was looking at and
- 33:08the PTAB was looking at before, and I think this
- 33:13has really continued on under director Squires,
- 33:16just no longer explicitly written explicitly.
- 33:20What the PTAB was really looking at was the data
- 33:23trial versus the date of the IPR ruling on the
- 33:26merits, which meant that as long as the trial
- 33:29date was set before the PTAB could finish its
- 33:33work, the IPR petition was going to be discretionarily
- 33:36denied, no matter how unrealistic that trial
- 33:39date was in reality, and no matter how strong
- 33:47the petition was on the merits. The Acting Director
- 33:53Stewart also introduced this concept of settled
- 33:56expectations, which is the age of the patent.
- 34:00And so the patent office was denying institution
- 34:04of IPR petitions in instances where the patent
- 34:09had issued, for example, more than six years
- 34:12ago under the theory that the patent owner because
- 34:20nobody had challenged the patent in that intervening
- 34:23six years, had developed, quote unquote, settled
- 34:26expectations in the validity of the patent. One
- 34:32could query whether that makes any sense at all.
- 34:36There's certainly no basis in the law for such
- 34:40a doctrine of settled expectations. There's nothing
- 34:46in any patent statutes or any case law that would
- 34:50say a patent that is older. is more likely to
- 34:56be valid than a patent that is younger. The standards
- 35:00for whether a patent is valid or not really turns
- 35:03on what we've talked about, whether the invention
- 35:06was disclosed in the prior art previously, or
- 35:11whether the patent has all of the... required
- 35:15elements that the statute requires in order for
- 35:19a patent to be a valid issued patent. what is
- 35:24considered when you look at the validity of a
- 35:26pet, not its age. So interesting whether this
- 35:31is a proper doctrine at all. And there's currently
- 35:36lawsuits challenging the settled expectations
- 35:39doctrine and whether it's supported by the statute
- 35:44or the Constitution. So how has that affected
- 35:49patent litigation today? So because of the weakening
- 35:54of IPRs and the diminished likelihood that the
- 36:00patent office will institute an IPR, there has
- 36:03been a large increase, perhaps not surprisingly,
- 36:08in the number of patent infringement cases filed
- 36:10in district courts. So just taking it. Two years
- 36:14as an example, there were about 3 ,800 new patent
- 36:19infringement cases filed in 2024. Sort of the
- 36:23last year under the old PTO regime versus 4 ,500
- 36:29new patent infringement cases filed in 2025.
- 36:33So 20 % increase. And in 2026, this year we're
- 36:38on track probably to exceed 5 ,000. new cases.
- 36:43So substantial increase in the number of new
- 36:46patent infringement cases, which is interesting
- 36:50because this sort of goes against the the whole
- 36:57reason that the America Advents Act, the AIA,
- 37:01came into existence, and the whole reason why
- 37:03this post -chapelage system was created in the
- 37:06first place. So, you know, it's interesting how
- 37:10times change and how views change over time.
- 37:15the AIA was a bipartisan act. It had support
- 37:20from, you know, Democrats and Republicans alike.
- 37:23It was considered to be a very pro -business,
- 37:27pro -technology act because there was a perceived
- 37:33plague of, you know, frivolous is one way to
- 37:40describe it, but a perceived deluge of patent
- 37:46infringement cases, you know, the early 2000s
- 37:49leading up to the passage of the AIA that plagued,
- 37:53you know, all major technology companies in the
- 37:56US and even foreign technology companies that
- 38:00do business in the US. And part of the rationale
- 38:05for passing the AIA and for creating this whole
- 38:07system was to hopefully reduce the number of
- 38:13patent infringement cases asserting weak patents,
- 38:18where the goal was to extract settlements from
- 38:24large technology companies, even though the patents
- 38:28themselves were weak and were probably invalid,
- 38:32but taking advantage of the cost of litigation,
- 38:35right? It would be cheaper to settle and pay
- 38:39the plaintiffs, even in weak cases, because it
- 38:43would be cheaper than actually litigating a case
- 38:46through the end in district court. The whole
- 38:49concept of these IPRs was to give defendants
- 38:55a cheaper way to challenge the validity of the
- 38:59patents. And the AIA was successful in many respects
- 39:06in the first decade of its existence. in doing
- 39:10that, the number of patent cases fell over time,
- 39:15you know, to the, you know, 3500 a year range
- 39:21from at one point, there were more than, you
- 39:24know, 6000 or 7000 new patent cases filed every
- 39:28year. And so now we seem to be sort of backtracking
- 39:31on that. And when we're seeing a steady rise,
- 39:34which, as long as these policies remain in place
- 39:38will likely continue for the next few years.
- 39:40So we are likely to get to record levels of patent
- 39:44infringement cases again. Next slide, please.
- 39:53So I've already talked about settled expectations.
- 39:57So I think I'll skip this, particularly since
- 40:00now we're not even getting sort of any. additional
- 40:05written decisions further explaining, you know,
- 40:08in which cases the PTAB believes that settled
- 40:12expectations have arisen or not. So next slide,
- 40:16please. So here, I just wanted to show you in
- 40:23table form, sort of the statistics over the last
- 40:27few years. And so you can see that in fiscal
- 40:31year 2020, which basically the way the patent
- 40:35office does their fiscal year is the U .S. government
- 40:37fiscal year. So it's September 1. So fiscal year
- 40:4225 is September 1, 2024 through August 31, 2025.
- 40:52So fiscal year 2025 was the first fiscal year
- 40:55at the PTO. where it was about 50 -50 between
- 40:59IPRs that were, this is discretionary denial,
- 41:05you know, 50 -50 denied versus not denied. Whereas
- 41:09in prior years, you can see it was a much, much
- 41:13higher institution rate. At fiscal year 2026,
- 41:17which began in September, 2025, you'll see that
- 41:24we're now at a point where the discretionary
- 41:28denials far outpace institution. So in overall
- 41:33numbers, only 200 or so IPRs have been instituted
- 41:41versus 500 that were denied institution. Next
- 41:48slide, please. So discretionary denials are at
- 41:57an all time high. So essentially the numbers
- 42:01show about 60 % of IPR discretionary denial requests
- 42:06are granted. Contrast that with a 32 % overall
- 42:12denial rate in 2024. That's quite a significant
- 42:16difference because so even of the, what that
- 42:20means is so even of the 40 % of of IPRs that
- 42:26survive discretionary denial, still a fair number
- 42:29of those are denied on the merits, right? So
- 42:31when now the director looks at the merits and
- 42:35the strength of the arguments of the petition,
- 42:37there's another significant number of those petitions
- 42:40that are denied on that ground as well. So the
- 42:45overall institution rate right now is about 24
- 42:49% when you take into account the merits and discretionary
- 42:55denial. And that's a sharp contrast, right? So
- 42:58the overall institution rate in 2024 was 68 %
- 43:03and now we're down to 24%. So that's a drastic
- 43:07change in your likelihood of being able to get
- 43:13an IPR instituted at the patent office. Next
- 43:17slide, please. So let me quickly talk about some
- 43:25of the alternatives and the pluses and minuses.
- 43:29And then I think we can stop and I'll try to
- 43:32answer any questions that folks have. So one
- 43:36alternative are post -grant reviews. We are starting
- 43:39to see an increase in the number of post -grant
- 43:43reviews filed. There's only a 29 % discretionary
- 43:47denial rate compared to the 60 % for IPRs. which
- 43:53makes sense because the settled expectations
- 43:56rule can't really apply to PGRs because those
- 44:00patents are brand new. They were just issued.
- 44:04So PGRs are an avenue if IPRs aren't available
- 44:12to defendants. Again, because there are so few
- 44:16lawsuits filed asserting brand new patents, that's
- 44:19only of limited utility. But that being said,
- 44:23I have filed a number of PGRs on behalf of clients
- 44:26who have been sued on newer patents. And we've
- 44:29been successful in getting those instituted and
- 44:32having the PTO proceed with review. So it is
- 44:35a good option, but only in those cases where
- 44:38the patent is brand new. The other alternative
- 44:43is something that has existed for decades. And
- 44:47prior to the AIA, this was the only avenue that
- 44:52people had to challenge patents at the U .S.
- 44:55Patent Office. But after the AIA in 2012, like
- 44:59basically ex parte reexaminations went out the
- 45:02window and nobody was using them. But today now
- 45:05there's been a huge resurgence in the number
- 45:07of ex parte reexaminations filed. The advantage,
- 45:12at least so far, although there may be changes
- 45:15to this, there's a very, very high grant rate.
- 45:19So about 90 % of the time that you request an
- 45:22ex parte re -examination, at least up until now,
- 45:27the patent office will undertake a re -examination.
- 45:32Now, this is not done by the PTAB. Re -examination
- 45:36is considered basically part of the prosecution
- 45:40process. So re -examination is considered by
- 45:44patent examiners, not the ALJs who handle post
- 45:48-grant challenges. The other advantages of ex
- 45:52parte re -examinations is there's no estoppel,
- 45:56meaning that there's no binding effects on a
- 45:59defendant in the district court case. They're
- 46:01also much, much cheaper, even than IPRs or PGRs.
- 46:06The reason for that is there, once you file your
- 46:12request for an ex parte re -examination, There
- 46:15are no discovery procedures like in an IPR and
- 46:20PGRs, meaning there's no expert witness reports
- 46:26and depositions that get submitted. You don't
- 46:29participate at all, right? So after you make
- 46:32a request, that ex parte reexamination requests
- 46:35the requester. So you do not get to participate
- 46:40after that. If the procedure is accepted, There's
- 46:44a dialogue back and forth just like in a normal
- 46:47patent prosecution case between the examiner
- 46:51who's looking at the patent and the patent owner.
- 46:56And so the requester does not play a part in
- 46:58the process. So for that reason, it's much cheaper.
- 47:01The disadvantage is, of course, is that you're
- 47:04not participating. You don't get to respond to
- 47:07the arguments that the patent owner is making.
- 47:11It's entirely dependent on the patent examiner
- 47:13to make the decision. So that means that from
- 47:19a challenger's point of view, ex parte re -examinations
- 47:23are often not as effective in invalidating patents.
- 47:27In many instances, the patent owner is able to
- 47:31persuade the examiner that the patent is still
- 47:33valid, or the patent owner can amend their claims
- 47:39during the ex parte re -examination to still
- 47:43get a patent with maybe new claims issued as
- 47:48a part of the process. Whereas in the IPR proceedings,
- 47:53it is much, much more difficult to amend your
- 47:56claims. Because of the large increase in the
- 48:04number of ex parte re -examinations that have
- 48:06been filed in the last year, the director has
- 48:11also changed the rules for ex parte re -examinations.
- 48:16It's too early to see what the effect of that
- 48:19will be. But now, previously, the requester of
- 48:25a ex parte re -exam would just make the request.
- 48:28The patent owner had no ability to try to oppose
- 48:32that. The patent office would just look at the
- 48:36request and make a decision on its own whether
- 48:39the request raised the substantial new question.
- 48:42That's the standard SNQ of validity or not. Now,
- 48:49as of April 2026, the patent owner can actually
- 48:52file an opposition in effect to state its arguments
- 48:57why the patent office should not even undertake
- 49:00a re -examination. As I said, we'll see what
- 49:04the impact of that is. It's a little too early
- 49:07to know how that affects the granting of re -examinations.
- 49:12Next slide, please. So this is just a graphic
- 49:17to show you the explosion and the number of re
- 49:21-examination filings in the last year. It's gone
- 49:26from... you know, five years ago, maybe 50 or
- 49:31so of them every quarter. This is broken down
- 49:35by quarter to, you know, in recent quarters,
- 49:38as many as 200, you know, more than 250 reexamination
- 49:43requests per quarter. So it's like five times
- 49:46as many as there were, you know, five years ago.
- 49:50So it's a huge explosion. So While the patent
- 49:54office has succeeded in reducing the burden on
- 49:58the PTAB and the number of IPR petitions, that's
- 50:03led to a huge increase and a huge burden on patent
- 50:07examiners who have to consider these re -examinations
- 50:11and query whether that's the right outcome of
- 50:16all of these procedural changes that the patent
- 50:20office has instituted. So next slide, let me
- 50:26wrap up and then I'll try to answer any questions.
- 50:30So just a few takeaways, I think, for patent
- 50:37defendants that are considering what to do in
- 50:40the wake of all of these changes. So first, this
- 50:44really means that if you are gonna file an IPR
- 50:47petition, you have to file it basically almost
- 50:49immediately once you have been sued because otherwise
- 50:53the trial date that's set by the court is gonna
- 50:57be before the IPR could finish. So it's really
- 51:00imperative now even more than it was before to
- 51:04file IPR petitions immediately so that the timing
- 51:07you can essentially beat the trial date. This
- 51:10also means that to the extent you can transfer
- 51:13your case out of Rocket Dock districts, two districts
- 51:17where the trial dates are set three years out,
- 51:21which would be way longer than the IPR timeline,
- 51:25the better off you are. So that means getting
- 51:28out of the Eastern District of Texas or the Western
- 51:32District of Texas or the Eastern District of
- 51:35Virginia, those districts that set trial dates.
- 51:38very, very fast. If you're in one of those, if
- 51:43your case remains in one of those districts,
- 51:45it's going to be almost impossible to have your
- 51:48IPR instituted under the current regime. You
- 51:52have to think about, given the current settled
- 51:55expectations doctrine that's been expressed by
- 51:59the PTO, whether it's even worth bringing an
- 52:02IPR challenge to older pets, because there's
- 52:06a very high likelihood it will be denied. no
- 52:09matter how quickly you file the petition. So
- 52:12as a result, you just have to, we all are sort
- 52:15of adjusting the expected value of IPR petitions
- 52:19and weighing whether the cost of the time investment
- 52:25is worth it. As I mentioned, PGRs remain an attractive
- 52:30option when available, but they're only available
- 52:33in limited circumstances. and so for now a lot
- 52:39of defendants are you know considering ex parte
- 52:43re -exams and are filing those even you know
- 52:47knowing all of the disadvantages that come with
- 52:51that. And so you have to weigh those disadvantages.
- 52:56But in many instances, as you can see from the
- 52:59numbers, defendants are choosing to pursue an
- 53:04ex parte re -exam strategy. So that was a very
- 53:09quick overview of everything that's going on
- 53:12at the Patent Office and how that affects litigation
- 53:15strategy. So we have a little bit of time left
- 53:19for questions. I hope that was helpful for everyone.
- 53:28Chris, it looks like we're still waiting for
- 53:30some questions to roll in. Do you have any other
- 53:32comments or takeaways that you'd like to? No,
- 53:38I think I've covered everything. So if there
- 53:40are questions, I'm happy to answer. And if not,
- 53:44I think we can end the session. All right, it
- 54:04looks like we received one question so far. Stephen
- 54:07is asking, can you describe the impacts of multiple
- 54:10claims? Multiple claims in a patent that are
- 54:17being challenged? Is that what the question is?
- 54:25Or multiple, you know, district court cases?
- 54:34All right, so there's a new worst claims in one
- 54:36pack. So the generally that will not. So under
- 54:50what it gets to the substantive evaluation. So
- 54:53it doesn't really matter for discretionary denial.
- 54:57at least as far as we know, now that Director
- 55:01Squires isn't publishing any rationale, we don't
- 55:06know exactly what he's taking into account. But
- 55:09as I think what we saw previously, there were
- 55:13no discretionary denials based on the number
- 55:15of claims that a patent you challenged. So that
- 55:21wasn't really a deciding factor. where that comes
- 55:25into play is sort of on the substantive evaluation
- 55:27of the IPR. The rule is supposed to be, and I
- 55:34believe the PTAB was applying this, and I think
- 55:36Director Squires is continuing to apply this
- 55:39in his evaluation of the merits. As long as there
- 55:43was, as long as you could show a reasonable...
- 55:48grounds for at least one of the challenge claims
- 55:52being invalid, the patent office is supposed
- 55:58to institute the IPR. So they might only institute
- 56:02that review as to that one challenge claim and
- 56:06not all of the claims that you challenged in
- 56:08your petition, but that's sort of the analysis
- 56:11that happens. So, and in terms of the strategy
- 56:17behind deciding which claims to challenge at
- 56:22the PTO, you generally have to challenge all
- 56:30of the asserted claims in the patent. And you
- 56:38would wanna do that in order to persuade the
- 56:41district court to stay the case because If you
- 56:45don't challenge all of the claims that have been
- 56:47asserted in the district court, then the patent
- 56:52order has at least the argument at the district
- 56:54court that, well, this isn't going to resolve
- 56:56everything anyways. Even if the patent office
- 57:01invalidates two of the five asserted claims,
- 57:04the case is still going forward. So why stay
- 57:07the case? Looks like we got another question.
- 57:16Do the same timing considerations and deadlines
- 57:17apply if patent infringement cross claims arise
- 57:20in an existing litigation matter, which do not
- 57:23previously involve patent claims? Patent infringement
- 57:29arise in an existing litigation matter. So the
- 57:36rules, and I guess I didn't talk at all about
- 57:39the rules, the timing rules on IPRs. So as we
- 57:45talked about for PGRs, you can only file within
- 57:50the first nine months after the patent is issued.
- 57:56And that wouldn't be affected by whether... the
- 58:00patent infringement claims arise sort of originally
- 58:05or in counterclaim or cross -claim. So for example,
- 58:10if there was a counterclaim or a cross -claim
- 58:12asserting a patent that had, as long as it had
- 58:15been issued in the last nine months, you could,
- 58:20I mean, as long as you're within the nine month
- 58:23period from when the patent issued, you could
- 58:26still file a PGR. For IPRs, the timing rules
- 58:31are a little different. For an IPR, you could
- 58:33actually file an IPR any time after a patent
- 58:38has issued, so there's no nine -month limit.
- 58:41However, if you are sued on that patent, if you're
- 58:49a defendant in a litigation, you have to file...
- 58:53your IPR challenge within one year of when you
- 58:56were served with the complaint. And if you do
- 58:59not challenge it within that one year, you've
- 59:02lost your ability to file the IPR. Other companies,
- 59:08other defendants who have not been sued could
- 59:11still continue to file IPRs challenging that
- 59:15patent. In other words, it doesn't cut off the
- 59:17window for anybody else. It cuts off the window
- 59:20for you. And the same rule there, the timing
- 59:26of that would run from when the counterclaim
- 59:28is asserted or the cross -claim is asserted,
- 59:32that one year window, not from when the case
- 59:35as a whole started. If the other claims, the
- 59:39original claims had nothing to do with that patent.
- 59:44The other thing to note, is if you file a declaratory
- 59:48judgment action in district court challenging
- 59:51a patent, challenging the validity of a patent,
- 59:54you are not allowed to then also bring an IPR
- 59:57at the patent office. So that's just something
- 1:00:00to be aware of from a practice standpoint. All
- 1:00:08right, it looks like that's it for questions
- 1:00:10today. Thank you so much for sharing your knowledge
- 1:00:14with our members and thank you so much to our
- 1:00:16audience for joining us today. Have a great day.
- 1:00:19Everybody. Thank you.